Diagnos Laboratorium Utama Tbk. vs Pelayaran Nasional Ekalya Purnamasari Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Pelayaran Nasional Ekalya Purnamasari Tbk. trades at Rp990 (market cap 7.54T, 1.19M 24h volume). The key difference: Pelayaran Nasional Ekalya Purnamasari Tbk. is far larger — about 24.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Pelayaran Nasional Ekalya Purnamasari Tbk. is more actively traded (1.19M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | ELPI | |
|---|---|---|
Market Cap | 310.75B | 7.54T |
Volume | 963.6K | 1.19M |
Lot | 9.64K | 11.86K |
Turnover | 217.67M | 1.18B |
Average Price | 225.89 | 993.6 |
Value | 217.67M | 1.18B |
Indicative Equilibrium Price | 226 | 990 |
Indicative Equilibrium Volume | 1K | 335 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pelayaran Nasional Ekalya Purnamasari Tbk (the Entity) was established based on Notarial Deed No. 11 of Grace Margareth Goenawan, S.H., dated April 20, 1992 in Ambon. PT Pelayaran Nasional Ekalya Purnamasari is the parent Entity, whereas PT Kreasi Cipta Timur is the ultimate parent of the Entity. The Entity’s Ultimate Beneficiary Ownership (UBO) is Eka Taniputra.
Read more on ELPI →